Adempas

Medicinal product

(Invented) name

Adempas

Active substance (s)

Riociguatas

Strength

0,15 mg

Pharmaceutical form

granulės geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C02KX05, Riociguat

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2022-07-07

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml paruoštos suspensijos yra	1 ml
Riociguatas	0,15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121329	107437	1107437	buteliukas	vandens švirkštas (100 ml), 2 mėlyni švirkštai (5 ml ir 10 ml), buteliuko adapteris N1		Receptinis	EU/1/13/907/021	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-07-07	Registruotas